contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-the-presentation-of-elektas-first-quarter-202223

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Elekta

STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2022/23 at 10:00 a.m. CEST on August 25. The interim report for the first quarter will be...

<div class="mfn-preamble">STOCKHOLM – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2022/23 at 10:00 a.m. CEST on August 25. The interim report for the first quarter will be published at 7:30 a.m. CEST on the same day.</div><div class="mfn-body">The company’s development will be presented by Elekta’s President and CEO Gustaf Salford together with CFO Tobias Hägglöv. After the presentation, held in English, a Q&amp;A session will follow. &nbsp; The presentation will be broadcasted live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording of the webcast can be found on Elekta’s website after the call. &nbsp; Welcome! &nbsp; Time: Thursday, August 25, at 10:00 a.m. CEST &nbsp; Telephone numbers to join phone conference: UK: +44&nbsp;207 107 0613 USA: +1&nbsp;631 570 5613 Sweden: +46 8 5051 0031 &nbsp; Webcast: <a rel="nofollow noopener" href="https://protect-eu.mimecast.com/s/FD9PCzX74h7LAoKh4HXAC?domain=elekta-qreports.creo.se">https://elekta-qreports.creo.se/220825</a># # #For further information, please contact: Cecilia Ketels, Head of Investor Relations Tel: +46 76 611 7625, e-mail: <a rel="nofollow noopener" href="mailto:cecilia.ketels@elekta.com">cecilia.ketels@elekta.com</a> Time zone: CET (Central European Time)</div><div class="mfn-footer mfn-about mfn-c95be5d56136">About Elekta<hr>As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 120 countries and listed on Nasdaq Stockholm. For more information, visit <a rel="nofollow noopener" href="http://www.elekta.com/">elekta.com</a> or follow <a rel="nofollow noopener" href="https://twitter.com/Elekta">@Elekta</a> on Twitter.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="nofollow noopener" class="mfn-generated mfn-primary" href="https://storage.mfn.se/4b2db2e5-23d5-4358-a45f-bd1f3e822664/invitation-to-the-presentation-of-elektas-first-quarter-2022-23.pdf">Invitation to the presentation of Elekta’s first quarter 2022/23</a></div>